Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in South Korea / NCT06211491
Recruiting Observational

Autonomic Dysreflexia in Spinal Cord Injuries: UDS Filling Speed Impact

NCT06211491 · tracked via the Priya Life Science South Korea tracker
Sponsor
Pusan National University Yangsan Hospital
Phase
Observational
Started
2025-01-08
Last updated
2026-01-14

Condition(s) studied

Spinal Cord InjuriesAutonomic DysreflexiaUDS Filling Speed

Investigational drug(s) / intervention(s)

Urodynamic test

Urodynamic test: Urodynamic testing is performed using saline solution at the same temperature as body temperature (37 degrees) at two injection speeds of 10 mL/min and 100 mL/min, respectively.

Study summary

In patients with spinal cord injury, the investigators want to understand and understand the differences in AD prevalence and characteristics according to bladder injection rate, and to determine which factors have a greater influence between bladder expansion or injection rate.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients with chronic spinal cord injury 6 months after receiving the award 2. Patients with confirmed AD due to bladder fullness in previous urodynamic test 3. Patients confirmed to have neurological damage level C1-T6, AIS A or B Exclusion Criteria: 1. Patients who cannot perform the test because their systolic blood pressure remains at 150 mmHg during the urodynamic test 2. Patients who cannot undergo testing due to hemodynamic instability 3. Patients who cannot undergo testing due to overt urinary tract infection

Primary outcome measure(s)

  • Bladder volume (ml) — Immediately after the test
    (1) at first AD at an infusion rate of 10 mL/min (2) at first AD at an infusion rate of 100 mL/min

Trial sites (1)

FacilityCityRegionStatus
Pusan National University Yangsan Hospital Yangsan Gyeongsangnam-do Recruiting

More Pusan National University Yangsan Hospital trials in South Korea

HB05P on Muscle Health Recruiting
Cardiovascular Autonomic Function After Resistance Training Starting soon
Ultrasound Guided Cervical Selective Nerve Root Block Versus Fluoroscopic Guided Cervical Transforaminal Epidural Block Active, not recruiting
The Study to Evaluate the Safety and Efficacy of the Onyx Family Recruiting
Electromagnetic High-Frequency Chest Wall Oscillation on Pulmonary Mucus Clearance in Patients With Impaired Self-Expectoration Recruiting

Other trials for the same condition

Exercise Program for Individuals With SCI in Community Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06211491 on ClinicalTrials.gov ↗ ← All trials in South Korea